Generated by GPT-5-mini| Phillip Frost | |
|---|---|
| Name | Phillip Frost |
| Birth date | 1936-04-02 |
| Birth place | United States |
| Occupation | Businessman, investor, philanthropist |
| Alma mater | University of Pennsylvania School of Medicine, University of Pennsylvania |
Phillip Frost is an American entrepreneur, investor, and philanthropist known for building and leading pharmaceutical, biotechnology, and media companies, as well as for major gifts to educational and cultural institutions. He has been a prominent figure in corporate governance, venture capital, and medical research philanthropy, with a career intersecting major organizations in the United States and Israel. Frost's activities have involved founding companies, serving on boards of directors, and participating in large-scale philanthropic initiatives.
Frost was born in 1936 and raised in the United States, attending University of Pennsylvania where he completed undergraduate studies and later earned a medical degree from the University of Pennsylvania School of Medicine. During his formative years he trained in clinical medicine and developed connections to institutions such as Mount Sinai Hospital (Manhattan), Harvard Medical School, and research centers in the United States that shaped his interest in biomedical entrepreneurship. His medical training overlapped with the postwar expansion of biomedical research funded by agencies like the National Institutes of Health and foundations such as the Gordon and Betty Moore Foundation.
Frost transitioned from clinical practice into industry, co-founding and leading companies across sectors including pharmaceuticals, biotechnology, media, and finance. He served as CEO and chairman at firms that interacted with major corporations like Allergan, Teva Pharmaceutical Industries, and Pharmacia. Frost participated in merger and acquisition activity involving investment banks and advisory firms such as Morgan Stanley, Goldman Sachs, and private equity groups, and his investment portfolio included holdings in public companies listed on exchanges like the NASDAQ and New York Stock Exchange. Over decades he collaborated with executives and investors including figures from Brett and Steven Rales-related ventures, and partnerships with investors linked to Kohlberg Kravis Roberts-style transactions. Frost's board service extended to multinational companies, venture-backed startups, and philanthropic entities, interfacing with governance frameworks under regulators such as the Securities and Exchange Commission.
Frost is most prominently associated with founding and scaling pharmaceutical and biotech enterprises, including leadership roles at companies that developed novel therapeutics and engaged in licensing with academic centers like Johns Hopkins University and Massachusetts Institute of Technology. He was a key figure in mergers that affected companies such as Ivax Corporation, which later became part of Teva Pharmaceutical Industries, and in transactions involving Univax Biologics-style entities and generics businesses. Frost's pharmaceutical ventures involved collaborations with pharmaceutical executives and scientists, and relationships with major pharmaceutical firms like Johnson & Johnson, Pfizer, and Merck & Co. His holdings at times included significant equity positions in companies subject to regulatory oversight by agencies such as the Food and Drug Administration and legal matters adjudicated in courts including the United States District Court for the Southern District of Florida. Frost also participated in drug development financing interacting with venture capital firms and public markets, including debt and equity offerings under the supervision of the Financial Industry Regulatory Authority.
Frost has been an active philanthropist, making large gifts to higher education, medical research, and cultural institutions. Major beneficiaries have included the University of Miami, Brandeis University, Mount Sinai Medical Center (Miami Beach), and the American Museum of Natural History. He and his family have supported endowed chairs, research centers, and capital projects, leading to named buildings and institutes in fields linked to neuroscience, molecular biology, and translational medicine. Frost's philanthropy connected him with leaders in academic administration and research such as presidents and deans from the University of Pennsylvania, Harvard University, and Israeli institutions including Weizmann Institute of Science and Tel Aviv University, fostering collaborations between biomedical research and translational commercialization. His donations have also supported cultural organizations like the Miami City Ballet and international initiatives involving the Hebrew University of Jerusalem.
Frost's career has included legal scrutiny and controversies relating to securities, corporate disclosures, and mergers. He has been involved in investigations and litigation overseen by the United States Department of Justice and civil actions in federal courts concerning matters such as insider trading allegations, disclosure practices, and corporate governance disputes. Some proceedings attracted regulatory attention from the Securities and Exchange Commission and led to settlements or litigation outcomes that drew commentary in major media outlets like The Wall Street Journal and The New York Times. High-profile corporate transactions he participated in sometimes prompted shareholder derivative suits and proxy contests involving activist investors and law firms experienced in corporate litigation.
Frost has been married and is a resident of South Florida, where he has been engaged with regional institutions such as Miami Dade College, Florida International University, and cultural organizations in Miami. He has received honors and awards from academic and philanthropic organizations, including honorary degrees and recognition from medical and business schools at institutions like the University of Pennsylvania, Brandeis University, and philanthropic bodies in Israel. Frost's social and professional circles have connected him with philanthropists, entrepreneurs, and academic leaders, and his named contributions have resulted in endowed professorships and facilities bearing his family name.
Category:American businesspeople Category:Philanthropists Category:American investors